Midcingulate involvement in progressive supranuclear palsy and tau positive frontotemporal dementia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 9, 2012, Pages 910-915

  Chiu, Wang Zheng ^a   Papma, Janne M ^a   De Koning, Inge ^a   Kaat, Laura Donker ^a   Seelaar, Harro ^a   Reijs, Ambroos E M ^a   Valkema, Roelf ^a   Hasan, Djo ^b   Boon, Agnita J W ^a   Van Swieten, John Cornelis ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Maasstad Hospital Rotterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; BEHAVIOR CHANGE; BRAIN MAPPING; BRAIN PERFUSION; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MIDCINGULATE CORTEX; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROOP TEST; TAUOPATHY; WISCONSIN CARD SORTING TEST;

EID: 84864803125     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-302035     Document Type: Article

References (40)

1. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-59.
2. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (SteeleeRichardsone Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9. (Pubitemid 26243849)
3. Albert ML, Feldman RG, Willis AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974;37 :121-30.
4. Schrag A, Selai C, Davis J, et al. Health-related quality of life in patients with progressive supranuclear palsy. Mov Disord 2003;18:1464-9. (Pubitemid 38035369)
5. Donker Kaat L, Boon AJ, Kamphorst W, et al. Frontal presentation in progressive supranuclear palsy. Neurology 2007; 69:723-9. (Pubitemid 47300928)
6. Johnson KA, Sperling RA, Holman BL, et al. Cerebral perfusion in progressive supranuclear palsy. J Nucl Med 1992;33:704-9.
7. Paviour DC, Price SL, Jahanshahi M, et al. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 2006;129:1040-9.
8. Blin J, Baron JC, Dubois B, et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol 1990;47:747-52. (Pubitemid 20208614)
9. Cordato NJ, Duggins AJ, Halliday GM, et al. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 2005;128:1259-66. (Pubitemid 40826180)
10. Josephs KA, Whitwell JL, Eggers SD, et al. Gray matter correlates of behavioral severity in progressive supranuclear palsy. Mov Disord 2011;26:493-8.
11. Eckert T, Tang C, Ma Y, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord 2008;23:727-33.
12. Guedj E, Allali G, Goetz C, et al. Frontal Assessment Battery is a marker of dorsolateral and medial frontal functions: a SPECT study in frontotemporal dementia. J Neurol Sci 2008;273:84-7.
13. Williams GB, Nestor PJ, Hodges JR. Neural correlates of semantic and behavioural deficits in frontotemporal dementia. Neuroimage 2005;24:1042-51. (Pubitemid 40164506)
14. Varrone A, Pagani M, Salvatore E, et al. Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease. Eur J Nucl Med Mol Imaging 2007;34:1071-81. (Pubitemid 46919555)
15. Teune LK, Bartels AL, de Jong BM, et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 2010;25 :2395-404.
16. Salmon E, Van der Linden MV, Franck G. Anterior cingulate and motor network metabolic impairment in progressive supranuclear palsy. Neuroimage 1997; 5:173-8. (Pubitemid 27483901)
17. Groschel K, Hauser TK, Luft A, et al. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage 2004;21:714-24. (Pubitemid 38229934)
18. Chiu WZ, Kaat LD, Seelaar H, et al. Survival in progressive supranuclear palsy and frontotemporal dementia. J Neurol Neurosurg Psychiatry 2010; 81:441-5.
19. Rosso SM, Donker Kaat L, Baks T, et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 2003;126:2016-22. (Pubitemid 37059441)
20. Anon. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994;57:416-18.
21. Golbe LI, Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain 2007;130:1552-65. (Pubitemid 47355915)
22. Claus JJ, van Harskamp F, Breteler MM, et al. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection. Eur J Nucl Med 1994;21:1044-51. (Pubitemid 24304429)
23. Rey A. L'Examen Clinique en Psychologie. Paris: Press Universitaire de France, 1958.
24. Verhage F. Intelligence and age: research among the Dutch between 7 and 77 years of age. Assen: Van Gorcum, 1964.
25. Van Laere KJ, Versijpt J, Koole M, et al. Experimental performance assessment of SPM for SPECT neuroactivation studies using a subresolution sandwich phantom design. Neuroimage 2002;16:200-16. (Pubitemid 34852484)
26. Kim EJ, Cho SS, Jeong Y, et al. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain 2005;128:1790-801. (Pubitemid 41373650)
27. Friston KJ, Holmes AP, Worsley KJ, et al. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995; 2:189-210. (Pubitemid 124008664)
28. Acton PD, Friston KJ. Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies. Eur J Nucl Med 1998;25:663-7. (Pubitemid 28377027)
29. Brett M, Anton J, Valabregue R, et al, eds. Region of interest analysis using an SPM toolbox. 8th International Conference on Functional Mapping of the Human Brain, June 2-6, 2002, Sendai, Japan, 2002. Neuroimage 2002;16:497.
30. Vogt BA. Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci 2005;6:533-44. (Pubitemid 40942820)
31. Yu C, Zhou Y, Liu Y, et al. Functional segregation of the human cingulate cortex is confirmed by functional connectivity based neuroanatomical parcellation. Neuroimage 2011;54:2571-81.
32. Varrone A, Pappata S, Caraco C, et al. Voxel-based comparison of rCBF SPECT images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks. Eur J Nucl Med Mol Imaging 2002;29:1447-54. (Pubitemid 35232046)
33. Torta DM, Cauda F. Different functions in the cingulate cortex, a meta-analytic connectivity modeling study. Neuroimage 2011;56:2157-72.
34. Klein RC, de Jong BM, de Vries JJ, et al. Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease. Mov Disord 2005;20:1021-30. (Pubitemid 41419520)
35. Schofield EC, Hodges JR, Macdonald V, et al. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord 2011;26:256-63.
36. Fujiwara H, Hirao K, Namiki C, et al. Anterior cingulate pathology and social cognition in schizophrenia: a study of gray matter, white matter and sulcal morphometry. Neuroimage 2007;36:1236-45. (Pubitemid 47007713)
37. Seeley WW, Carlin DA, Allman JM, et al. Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurol 2006;60:660-7. (Pubitemid 46048483)
38. Ghosh BC, Rowe JB, Calder AJ, et al. Emotion recognition in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2009;80:1143-5.
39. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996; 55:97-105. (Pubitemid 26013790)
40. Chen JJ, Rosas HD, Salat DH. Age-associated reductions in cerebral blood flow are independent from regional atrophy. Neuroimage 2011; 55:468-78.